CD4(+) Th1 to the rescue in HER-2+ breast cancer

le Lowenfeld, Lea, Xu, Shuwen, Czerniecki, Brian J.
Foilsithe in Oncoimmunology (2018)

Oncodriver inhibition and CD4(+) Th1 cytokines cooperate through Stat1 activation to induce tumor senescence and apoptosis in HER2+ and triple negative breast cancer: implications...

le Rosemblit, Cinthia, Datta, Jashodeep, Lowenfeld, Lea, Xu, Shuwen, Basu, Amrita, Kodumudi, Krithika, Wiener, Doris, Czerniecki, Brian J.
Foilsithe in Oncotarget (2018)

Optimizing Dendritic Cell-Based Approaches for Cancer Immunotherapy

le Datta, Jashodeep, Terhune, Julia H., Lowenfeld, Lea, Cintolo, Jessica A., Xu, Shuwen, Roses, Robert E., Czerniecki, Brian J.
Foilsithe in Yale J Biol Med (2014)

Anti-HER2 CD4(+) T-helper type 1 response is a novel immune correlate to pathologic response following neoadjuvant therapy in HER2-positive breast cancer

le Datta, Jashodeep, Berk, Erik, Xu, Shuwen, Fitzpatrick, Elizabeth, Rosemblit, Cinthia, Lowenfeld, Lea, Goodman, Noah, Lewis, David A, Zhang, Paul J, Fisher, Carla, Roses, Robert E, DeMichele, Angela, Czerniecki, Brian J
Foilsithe in Breast Cancer Res (2015)

Addition of anti-estrogen therapy to anti-HER2 dendritic cell vaccination improves regional nodal immune response and pathologic complete response rate in patients with ER(pos)/HER...

le Lowenfeld, Lea, Zaheer, Salman, Oechsle, Crystal, Fracol, Megan, Datta, Jashodeep, Xu, Shuwen, Fitzpatrick, Elizabeth, Roses, Robert E., Fisher, Carla S., McDonald, Elizabeth S., Zhang, Paul J., DeMichele, Angela, Mick, Rosemarie, Koski, Gary K., Czerniecki, Brian J.
Foilsithe in Oncoimmunology (2016)